Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-γ

European Journal of Pharmacology

Volumn 566, Issue 1-3, 2007, Pages 192-199

  De Stefano, Daniela ^a   Maiuri, Maria Chiara ^a   Simeon, Vittorio ^a   Grassia, Gianluca ^a   Soscia, Antonio ^a   Cinelli, Maria Pia ^a   Carnuccio, Rosa ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Celiac disease; Gliadin; Interferon gamma; RAW 264.7 macrophage; Transcription factors

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; GLIADIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; LYCOPENE; QUERCETIN; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; TYROSOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; INFLAMMATION; INHIBITION KINETICS; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; CAROTENOIDS; CELIAC DISEASE; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIADIN; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; INTERFERON-STIMULATED GENE FACTOR 3; MACROPHAGE ACTIVATION; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PHENYLETHYL ALCOHOL; QUERCETIN; REACTIVE OXYGEN SPECIES;

EID: 34249048898     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.03.051     Document Type: Article

References (49)

1. Beckett C.G., Dell'Olio D., Ellis H.J., Rosen-Bronson S., and Ciclitira P.J. The detection and localization of inducible nitric oxide synthase production in the small intestine of patients with coeliac disease. Eur. J. Gastroenterol. Hepatol. 10 (1998) 641-647
2. Beckett C.G., Dell'Olio D., Shidrawi R.G., Rosen-Bronson S., and Ciclitira P.J. Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies. Eur. J. Gastroenterol. Hepatol. 11 (1999) 529-535
3. Ciccocioppo R., Di Sabatino A., Bauer M., Della Riccia D.N., Bizzini F., Biagi F., Cifone M.G., Corazza G.R., and Schuppan D. Matrix metalloproteinase pattern in celiac duodenal mucosa. Lab. Invest. 85 (2005) 397-407
4. D'Acquisto F., de Cristofaro F., Maiuri M.C., Tajana G., and Carnuccio R. Protective role of nuclear factor kappa B against nitric oxide-induced apoptosis in J774 macrophages. Cell Death Differ. 8 (2001) 144-151
5. de la Puerta R., Martinez Dominguez M.E., Ruiz-Gutierrez V., Flavill J.A., and Hoult J.R. Effects of virgin olive oil phenolics on scavenging of reactive nitrogen species and upon nitrergic neurotransmission. Life Sci. 69 (2001) 1213-1222
6. De Stefano D., Maiuri M.C., Iovine B., Ialenti A., Bevilacqua M.A., and Carnuccio R. The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. J. Mol. Med. 84 (2006) 65-74
7. Decker T., Lew D.J., Mirkovitch J., and Darnell Jr. J.E. Cytoplasmic activation of GAF, an interferon-gamma-regulated DNA-binding factor. EMBO J. 10 (1991) 927-932
8. Di Carlo G., Mascolo N., Izzo A.A., and Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci. 65 (1999) 337-353
9. Dolfini E., Elli L., Ferrero S., Braidotti P., Roncoroni L., Dasdia T., Falini M.L., Forlani F., and Bardella M.T. Bread wheat gliadin cytotoxicity: a new three-dimensional cell model. Scand. J. Clin. Lab. Invest. 63 (2003) 135-141
10. Epinat J.C., and Gilmore T.D. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway. Oncogene 18 (1999) 6896-6909
11. Faure V., Hecquet C., Courtois Y., and Goureau O. Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells. J. Biol. Chem. 274 (1999) 4794-4800
12. Fletcher B.S., Kujubu D.A., Perrin D.M., and Herschman H.R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267 (1992) 4338-4344
13. Gao J., Morrison D.C., Parmely T.J., Russell S.W., and Murphy W.J. An interferongamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J. Biol. Chem. 272 (1997) 1226-1230
14. Garoufalis E., Kwan I., Lin R., Mustafa A., Pepin N., Roulston A., Lacoste J., and Hiscott J. Viral induction of the human beta interferon promoter: modulation of transcription by NF-κB/Rel proteins and interferon regulatory factors. J. Virol. 68 (1994) 4707-4715
15. Gianfrani C., Auricchio S., and Troncone R. Adaptive and innate immune responses in celiac disease. Immunol. Lett. 99 (2005) 141-145
16. Grisham M.B., Pavlick K.P., Laroux F.S., Hoffman J., Bharwani S., and Wolf R.E. Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease. J. Investig. Med. 50 (2002) 272-283
17. Harada H., Takahashi E., Itoh S., Harada K., Hori T.A., and Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14 (1994) 1500-1509
18. Heber D., and Lu Q.Y. Overview of mechanisms of action of lycopene. Exp. Biol. Med. (Maywood) 227 (2002) 920-923
19. Hecker M., Preiss C., Klemm P., and Busse R. Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor kappa B and interferon regulatory factor 1. Br. J. Pharmacol. 118 (1996) 2178-2184
20. Holmgren Peterson K., Falth-Magnusson K., Magnusson K.E., Stenhammar L., and Sundqvist T. Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge. Scand. J. Gastroenterol. 33 (1998) 939-943
21. Kainulainen H., Rantala I., Collin P., Ruuska T., Paivarinne H., Halttunen T., Lindfors K., Kaukinen K., and Maki M. Blisters in the small intestinal mucosa of coeliac patients contain T cells positive for cyclooxigenase 2. Gut 50 (2002) 84-89
22. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S.I., Kimura T., and Green S.J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263 (1994) 1612-1615
23. Kim H.Y., Park E.J., Joe E.H., and Jou I. Curcumin suppresses Janus Kinase-STAT inflammatory signalling through activation of Src Homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J. Immunol. 171 (2003) 6072-6079
24. Kinugawa K., Shimizu T., Yao A., Kohmoto O., Serizawa T., and Takahashi T. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ. Res. 81 (1997) 911-921
25. Kontakou M., Przemioslo R.T., Sturgess R.P., Limb A.G., and Ciclitira P.J. Expression of tumor necrosis factor-alpha, interleukin-6, and interleukin-2mRNA in the jejunum of patients with coeliac disease. Scand. J. Gastroenterol. 37 (1995) 52-57
26. Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O., Takashi E., and Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem. 221 (1994) 889-897
27. Kroger A., Koster M., Schroeder K., Hauser H., and Mueller P.P. Activities of IRF-1. J. Inter. Cytok. Res. 22 (2002) 5-14
28. Lavö B., Knutson L., Lööf L., and Hällgren R. Gliadin challenge-induced jejunal prostaglandin E2 secretion in celiac disease. Gastroenterologist 99 (1990) 703-709
29. Lowenstein C.J., Alley E.W., Raval P., Snowmann A.M., Snayder S.H., Russel S.W., and Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon-g and lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9730-9734
30. Maiuri L., Troncone R., Mayer M., Coletta S., Picarelli A., De Vincenzi M., Pavone V., and Auricchio S. In vitro activities of A-gliadin related synthetic peptides: damaging affect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. Scand. J. Gastroenterol. 31 (1996) 247-253
31. Maiuri M.C., De Stefano D., Mele G., Fecarotta S., Greco L., Troncone R., and Carnuccio R. Nuclear factor kappa B is activated in small intestinal mucosa of celiac patients. J. Mol. Med. 81 (2003) 373-379
32. Maiuri M.C., De Stefano D., Di Meglio P., Irace C., Savarese M., Sacchi R., Cinelli M.P., and Carnuccio R. Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. N. S. Arch. Pharmacol. 371 (2005) 457-465
33. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterologist 102 (1992) 330-354
34. Neish A.S., Read M.A., Thanos D., Pine R., Maniatis T., and Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell. Biol. 15 (1995) 2558-2569
35. Ohmori Y., and Hamilton T.A. Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J. Biol. Chem. 268 (1993) 6677-6688
36. Pahl H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18 (1999) 6853-6866
37. Pavlick K.P., Laroux F.S., Fuseler J., Wolf R.E., Gray L., Hoffman J., and Grisham M.B. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic. Biol. Med. 33 (2002) 311-322
38. Pender S.L.F., Lionetti P., Murch S.H., Wathan N., and Mac Donald T.T. Proteolytic degradation of intestinal mucosa extracellular matrix after lamina propria T cell activation. Gut 39 (1996) 284-290
39. Ramana C.V., Chatterjee-Kishore M., Nguyen H., and Stark G.R. Complex roles of Stat1 in regulating gene expression. Oncogene 19 (2000) 2619-2627
40. Salvati V.M., MacDonald T.T., del Vecchio Blanco G., Mazzarella G., Monteleone I., Vavassori P., Auricchio S., Pallone F., Troncone R., and Monteleone G. Enhanced expression of interferon regulatory factor-1 in the mucosa of children with celiac disease. Pediatr. Res. 54 (2003) 312-318
41. Santamaria R., Irace C., Festa M., Maffettone C., and Colonna A. Induction of ferritin expression by oxalomalate. Biochim. Biophys. Acta 1691 (2004) 151-159
42. Seidel H.M., Milocco L.H., Lamb P., Darnell Jr. J.E., Stein R.B., and Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3041-3045
43. Sido B., Hack V., Hochlehnert A., Lipps H., Herfarth C., and Droge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 42 (1998) 485-492
44. Sims S.H., Cha Y., Romine M.F., Gao P.Q., Gottlieb K., and Deisseroth A.B. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor-1 promoter. Mol. Cell. Biol. 13 (1993) 690-702
45. Sirois J., Levy L.O., Simmons D.L., and Richards J.S. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. J. Biol. Chem. 268 (1993) 12199-12206
46. Sollid L.M. Celiac disease as a model of gastrointestinal inflammation. J. Pediatr. Gastroenterol. Nutr. 40 Suppl 1 (2005) S41-S42
47. Stahlberg M.R., Hietanen E., and Maki M. Mucosal biotransformation rates in the small intestine of children. Gut 29 (1988) 1058-1063
48. ter Steege J., Buurman W., Arends J.W., and Forget P. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab. Invest. 77 (1997) 29-36
49. van Straaten E.A., Koster-Kamphuis L., Bovee-Oudenhoven I.M., van der Meer R., and Forget P.-Ph. Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr. 88 (1999) 528-531